The physiological relevance of CD14+/ColI+ cells in the pathogenesis of SSc-ILD is further supported by our observation that these cells are present in the lung tissue of SSc-ILD patients, but not that of control subjects. This evidence concerns the gene CD14 and systemic sclerosis.